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Abstract
Intranasal application of vesicular stomatitis virus (VSV) induces acute encephalitis characterized
by a pronounced myeloid and T cell infiltrate. The role of distinct phagocytic populations on VSV
encephalitis was therefore examined in this study. Ablation of peripheral macrophages did not
impair VSV encephalitis or viral clearance from the brain, whereas, depletion of splenic marginal
dendritic cells impaired this response and enhanced morbidity/mortality. Selective depletion of
brain perivascular macrophages also suppressed this response without altering viral clearance.
Thus, two anatomically distinct phagocytic populations regulate VSV encephalitis in a non-




Vesicular stomatitis virus (VSV) is a neurotrophic ssRNA virus of the Vesiculovirus genus
in the Rhabdoviridae family and is the prototypic virus of this family that includes rabies
virus. Following systemic infection, immunocompetent mice rapidly clear VSV from
peripheral organs, produce IgM and neutralizing IgG antibodies and mount a robust CTL
response although viral antigens persist for weeks in peripheral tissues. (Battegay et al.,
1996; Charan et al., 1986; Turner et al., 2007). When VSV is delivered via the intranasal
route, it initially infects and replicates in olfactory receptor neurons and is then transmitted
via the olfactory nerve to the central nervous system (CNS) within 12–24 hours (Forger et
al., 1991; Reiss et al., 1998). VSV replicates invasively in the olfactory bulb (OB)
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penetrating deeper layers of this structure, reaching the OB ventricle by days 4–5 post
infection producing focal cytopathology. Depending on the dose and strain, virus can enter
the ventricles causing inflammation and necrosis around the ventricles and travel caudally to
the hindbrain by day 8 post infection VSV does not use the trigeminal nerve for entry into
the brain, as the trigeminal ganglion remains virus-free following intranasal infection.
Although VSV infection of the CNS is associated with a high rate of morbidity and
mortality, surviving mice completely clear infectious virus from the brain around days 10–
12.
The observation that some mice survive CNS infection with this virus suggests that innate
and adaptive antiviral mechanisms are activated in the CNS. With respect to innate
immunity, prior immunohistochemical studies by Reiss and colleagues indicated that
intranasal infection with VSV activated glial cells (astrocytes, microglia) initially in the OB
and induced expansion of these resident cell populations (Bi et al., 1995). Activation of
astrocytes and microglia was likely responsible for the reported T cell-independent
encephalitis seen with this virus (Frei et al., 1989; Nansen et al., 2000). In addition to the
innate response in the CNS, adaptive immunity also contributes to host resistance because
SCID and nude mice invariably succumb to a fatal encephalitis but can be rescued by
adoptively transferred T cells (Coons et al., 1991; Hummer et al., 1990). Similarly,
antibody-mediated depletion of CD8+ or CD4+ T cells renders mice susceptible to VSV
replication and dissemination to the CNS (Huneycutt et al., 1993). According to the current
paradigm, T cells activated in the draining cervical lymph node (CLN) navigate through the
blood brain barrier (BBB) to mediate their antiviral effector functions. Although the precise
mechanism(s) by which T cells extravasate through the vascular endothelium and enter the
CNS parenchyma are not fully understood, several adhesion molecules such as CD11a
(LFA-1), CD11b (Mac-1) and CD49d (VLA-4) are upregulated on T cells isolated from
brains of VSV infected mice (Steel et al., 2009). Once VSV-activated T cells penetrate the
BBB, they are thought to follow CC and CXC chemokine gradients produced in the
encephalitic brain (Ireland and Reiss, 2006) to localize at sites of virus replication and/or
antigen deposition, a view consistent with immunohistochemical studies. It should be noted
that VSV globally activates T cells irrespective of antigen specificity. For example, 24 hours
post infection, the majority of CD8+ and to a lesser extent CD4+ T cells express CD69 and
CD25 (unpublished observation) and this far exceeds estimated precursor frequencies for
VSV-specific T cells (Ciavarra and Tedeschi, 1994). Even at the peak of the CD8+ T cell
response in the brain, ≤ 30% of CD8+ T cells are specific for the single immunodominant
nuclear protein epitope (VSV-N52–59) although the vast majority of CD8+ T cells express
late activation antigens CD49d (VLA-4) and CD11a (Steel et al., 2009). Thus, the specificity
of a significant fraction of CD8+ T cells that infiltrates the CNS following infection with
VSV remains to be clarified.
We have previously reported a multi-colour flow cytometric characterization of the cells that
infiltrate the brain during VSV encephalitis in normal mice and mice rendered deficient of
peripheral DCs (Steel et al., 2009). In this report we extend these studies to examine how
distinct populations of macrophages (mΦ) regulate VSV encephalitis and viral clearance in
the brain.
2. Materials and Methods
Mice and virus infection
Breeding pairs of macrophage fas-induced apoptosis (MAFIA) mice were purchased from
Jackson Laboratories (Bar Harbor, ME) and subsequently bred in-house. These mice express
a bicistronic mRNA encoding both EGFP and transgenic cytoplasmic Fas domains under the
control of the c-fms promoter (Burnett et al., 2004). Mice were phenotyped for endogenous
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EGFP by flow cytometry performed on blood obtained by tail prick. Mice lacking EGFP
expression were used as controls. Wild-type VSV-Indiana strain, provided by Dr. Philip
Marcus, University of Connecticut, was grown and assayed as previously described
(Marvaldi et al., 1977). Virus was grown in confluent monolayers of Vero cells and virus
titers determined by standard plaque assays (Sekellick and Marcus, 1979). VSV was
introduced into the brain via intranasal application of 5μl/nostril with either 5×104 (male) or
2×105 (female) PFU VSV (Barna et al., 1996). All experiments were performed in
accordance with federal guidelines and under an Institutional Animal Care and Use
Committee-approved protocol.
Cell isolation and depletion
Brains were excised, individually homogenized and then subjected to discontinuous Percoll
centrifugation to enrich for microglia and leukocytes as previously described (Steel et al.,
2009). Single cell suspensions of peripheral organs (spleen, draining cervical lymph nodes
(CLNs), lung) were scrubbed through 40 μ nylon mesh cell strainers. Erythrocytes were
lysed as necessary using BD PharmLyse Ammonium Chloride lysing reagent (Becton
Dickinson, Carlsbad, CA). Peripheral mΦ depletion was achieved by administration of five
consecutive intravenous injections of 10mg/kg AP20187 (Ariad Pharmaceuticals,
Cambridge, MA) via the lateral tail vein or the retro-orbital venous sinus as previously
described [5]. Alternatively, mice were depleted of peripheral mΦ by a single intravenous
(retro-orbital sinus) injection of liposome-encapsulated Cl2MBP (dichloromethylene
bisphosphonate, clodronate) kindly provided by Roche Diagnostics GmbH, Mannheim,
Germany. Depletion of brain PVMs (PVM) was achieved by intracerebroventricular (ICV)
injection of clodronate following a previously reported protocol (Galea et al., 2005). Briefly,
following induction mice were weighed and the surgical site prepared by shaving, swabbing
with betadine and a final swab with 70% ethanol. Mice given subcutaneous injections of
potassium penicillin (100 IU/g body weight, 100 μL) and gentamicin (0.005 mg/g body
weight, 100 μL) prior to surgery were then placed in a stereotaxic frame. An incision was
made along the coronal suture and the scalp was retracted. The position of the left lateral
ventricle was determined relative to the bregma as AP −0.5 mm, ML −1.0 mm, and DV
−2.0mm. A small hole was drilled into the skull and clordronate infused at a rate of 0.67 μL/
min for 12 min (8 μL per mouse). The skull was filled with bone wax and the scalp sutured.
Mice were allowed to recover for 3 days prior to experimental manipulation. Table 1
indicates the cell populations reported to be depleted following the indicated treatment.
Multicolour Flow Cytometry
Unless indicated otherwise, monoclonal antibodies (mAbs) against cell surface antigens
were purchased from eBioscience (San Diego, CA). Cells were stained and washed in flow
cytometry wash buffer (PBS supplemented with 1% goat serum and 0.1% sodium azide).
The following mAbs were used in this study: CD11b, clone M1/70; CD45, clone 30-F11;
MHC II, clone M5/114.15.2; CD11c, clone N418; CD4, clone GK1.5; CD8α, clone 53-6.7;
CD49b, clone DX5; CD45R, clone RA3-6B2; MHC I, clone 34-1-2S; PD-1, clone J43;
CD49d, clone R1-2; CD115, clone AFS98; CD40, clone 1C10; CCR7, clone 4B12; and
CD80, clone 16-10A1. PDCA-1 (clone JF05-1C2.4.1) was purchased from Miltenyi Biotec,
Auburn, CA. Tetramers directed against the immunodominant VSV nucleocapsid protein
(VSV-N52–59, RGYVYQGL) were obtained from the NIH Tetramer Core Facility.
Fluorophore conjugates varied based on staining profiles used. Acquisition of 20–200,000
events was performed using a Becton Dickinson (San Diego, CA) FACSCalibur using
CellQuest software (v3.3, Becton Dickinson). Acquired cells were analyzed using FlowJo
software (Tree Star, Ashland, OR). Non-specific binding in the absence of additional Fc
block was previously evaluated and did not affect staining patterns. To determine the
absolute number of microglia and infiltrating leukocytes in the CNS, a leukocyte gate was
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first defined for these cells based on forward and side scatter characteristics. Preliminary
studies verified that these gated cells were CD45+ and viable (≥95%propidium iodide and
annexin negative). The percentage of microglia (CD45low/int) or infiltrating blood cells
(CD45high) within this gate was then used to calculate cell recoveries. All gates and
quadrants were established with the use of appropriate isotype controls.
3. Results
To access the efficacy of mΦ depletion, MAFIA mice were treated with dimerizer and at the
indicated times peritoneal exudates cells (PECs) were evaluated by microscopy and flow
cytometry. It is apparent from Figure 1 that EGFP+ PECs isolated from untreated mice were
primarily mΦ because of high EGFP expression (panel b), histological appearance (panel c)
and F4/80 expression (data not shown). EGFPlow cells were also primarily mΦ as judged by
histological criteria (data not shown). As expected, AP20187 treatment markedly depleted
EGFPhigh cells (panel e). The remaining EGFP+ cells displayed high autofluorescence and
were primarily foamy and apoptotic mΦ (panel f). Dimerizer treatment was associated with
increased numbers of peritoneal EGFPlow cells (panel e). When sorted, these cells had the
morphology of granulocytes or band cells (panel g) and expressed the monocyte/granulocyte
marker Gr-1 (pane B). EGFPlowGr-1+ cells remained the predominant population in the
peritoneum for at least two-week post depletion (panel C). Thus, AP20187 treatment
depletes primarily EGFPhigh mΦ. The peritoneum is then repopulated primarily by EGFPlow
cells with a morphology and phenotype characteristic of granulocytes.
VSV encephalitis in MAFIA mice and MAFIA mice rendered deficient of peripheral
macrophages
We previously reported that VSV encephalitis is characterized by a prominent
CD45highCD11b+ infiltrate in the brain, a phenotype typically associated with mΦ (Ciavarra
et al., 2006). We therefore sought to determine the functional importance of peripheral mΦ
in the antiviral immune response in the CNS and whether this infiltrate was derived from
circulating monocytes. To address these questions, MAFIA mice were treated with AP20187
to deplete cells of the monocytes/mΦ lineage (Burnett et al., 2004) and the following day
given a single intranasal application of VSV. Control MAFIA mice were given just VSV or
AP20187. Treatment of MAFIA mice with AP20187 alone did not diminish resident
CD45low/intCD11b+ microglia relative to untreated B6 mice (Figure 2, box panels a–d). Two
populations of MAFIA microglia were detected based on EGFP expression (see Figure 3,
panels a–c), an observation consistent with high (≥50%) expression of CD115 (colony
stimulating factor receptor-1) on microglia from mock and VSV infected mice (unpublished
observation). VSV induced upregulation of microglial MHC class II antigens and this
activation occurred independent of peripheral mΦ (panels e–h). Microglia remained
uniformly F4/80+Gr-1- even at the peak of the inflammatory response (unpublished
observation). Despite depletion of peripheral monocytes/macrophages, a pronounced
population of CD45highCD11b+ cells still accumulated in the brains of these mice (compare
panels a–d). Further characterization revealed a trace population of resident DCs (CD11c+)
in naive mice that expanded modestly in both virus-infected groups. Whether brain
associated DCs are derived from blood DCs or immature monocytes that differentiate into
DCs once in the brain parenchyma remains to be determined. Plasmacytoid DCs (CD11c
+PCDA-1+) were not detected in encephalitic brains at any time following infection with
VSV (panels i-l). Ablation of peripheral mΦ did not impair the accumulation of CD8+ T
cells in the CNS. Tetramer staining revealed two CD8+CD49d+ expanded populations
induced by VSV irrespective of dimerizer treatment, one specific for VSV (tetramer+) and a
second with unknown specificity (Figure 2, tetramer-, panels m-p). Mice depleted of mΦ
remained healthy during the course of this experiment indicating efficient viral clearance
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from the CNS, whereas two VSV infected mice developed hind limb paralysis 6 days post
infection. We observed no significant differences in survival rates between intact and
dimerizer treated MAFIA following intranasal application of VSV. Thus, these data
demonstrate that acute depletion of peripheral mΦ does not impair VSV encephalitis or
clonal expansion of CD8+ T cells including the subset specific for immunodominant epitope
of VSV. Similar conclusions are reached when data are calculated as absolute cell recoveries
(Figure 2, panel B).
Macrophage depletion is associated with a pronounced and sustained granulocytic
response in haematopoietic and non-hematopoietic tissues during VSV encephalitis
The presence of a pronounced infiltrate of CD45highCD11b+ cells in the brains of VSV
infected MAFIA given dimerizer raised the possibility that mΦ depletion was either not
efficient or sustained in virus-infected animals. Alternatively, the CD45highCD11b+
infiltrate may not contain mΦ but another cell type like granulocytes that also express this
phenotype. To examine the former possibility, we repeated the experiment and also
evaluated the extent to which CD45highCD11b+ cells remained depleted in the peritoneum
and bone marrow during the peak of the encephalitic response. As demonstrated previously,
depletion of peripheral mΦ did not alter the encephalitic response (Figure 3, panels a–c and
data not shown). Analysis of the peritoneum of these mice indicated that naïve mice
contained a prominent population of CD45highCD11b+ cells that diminished modestly and
then expanded in mice given VSV or VSV plus dimerizer, respectively (panels d–f and
Figure 3B). This population contained both EGFPlow/int and EGFPhigh subsets, the latter
markedly diminished by VSV infection and was no longer detectable in mice given
dimerizer and VSV (panels g–i). The EGFPlow/int population was more stable in VSV
infected mice and expanded slightly in mice given both dimerizer and VSV.
CD45highCD11b+EGFPlow/int cells were predominately Gr-1- indicating that these cells
were likely immature mΦ and not granulocytes (panels g–i). Thus, the peritoneum of VSV
infected mice given dimerizer remained essentially devoid of mΦ (CD45highCD11b+Gr-1-
EGFPhigh) even 8 days post dimerizer treatment. There appeared to be a compensatory
increase in immature mΦ (CD45highCD11b+Gr-1-EGFPlow/int) in the peritoneum. Similar
conclusions were reached when total cell recoveries were calculated (Figure 3, panel B). In
the haematopoietic bone marrow, the number of CD45highCD11b+ cells remained fairly
stable regardless of the experimental manipulation (panels j-l and Figure 2C). In naïve
MAFIA mice, this CD45highCD11b+ population contained only a EGFPlow/int subset that
was markedly reduced in virus-infected animals but expanded in the dimerizer treated group
(panel m-o). In contrast to the peritoneum, virtually all CD11b+ cells in the bone marrow
expressed Gr-1. When cells recoveries were calculated for these different populations,
similar conclusions were reached (Figure 3C). Thus, dimerizer treatment results in the
sustained elimination of peripheral mΦ (CD45ighC11b+EGFPhighGr-1-) even in virus-
infected mice. The bone marrow mounts a potent compensatory response composed
primarily of granulocytes (CD45highCD11b+Gr-1+EGFPow/int) some of which may migrate
into the encephalitic brain.
VSV encephalitis is impaired in mice given liposome-encapsulated clodronate
To further characterize the CD45highCD11b+ infiltrate and to compare studies in the
MAFIA model with an established procedure for depletion of blood monocytes and tissue
mΦ, MAFIA mice were given a single intravenous injection of liposome-encapsulated
clodronate. This “suicide” technique depletes cells of the monocyte/mΦ lineage in the bone
marrow, spleen and liver but not peripheral lymph nodes including the draining cervical
lymph nodes (CLNs) (Van Rooijen et al., 1990). The following day mice were given an
intranasal instillation of VSV and 7 days post infection the cellular infiltrate was analyzed
by 4-color flow cytometry. Microglia isolated from naïve mice remained uniformly F4/80+,
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did not express the granulocytic marker Gr-1 and sustained this CD45low/intCD11b
+F4/80+Gr-1-phenotype in the encephalitic brain (data not shown). VSV induced a
pronounced infiltrate dominated by CD45highGr-1+F4/80− EGFP+/− cells, a phenotype
characteristic of neutrophils and not mΦ (Figure 4, panels a-l). Clodronate treatment
markedly suppressed this response as well as the infiltration of conventional myeloid
(CD8−) and lymphoid (CD8+) DCs (panels m–r). Encephalitic brains contained a CD11c-
PDCA-1+ population whose lineage and function will require further investigation.
Clodronate treatment also inhibited the accumulation of CD8+ T cells (panels p–r) including
VSV-specific T cells (panels s–u) in the CNS. Similar conclusions were reached when cell
recoveries were calculated from multiple experiments (panels B, C). Thus, in striking
contrast to the MAFIA model, liposome-encapsulated clodronate profoundly suppressed
VSV encephalitis. In addition, clodronate-treated mice showed increased morbidity and
mortality relative to mice given just VSV. Half of the mice (3/6) died at 6 days post-
infection (two days earlier than typical onset of morbidity for this strain) and by 7 days post-
infection the remaining mice were moribund, while untreated VSV-infected mice showed
only early signs of pathogenesis (panel D). Morbidity/mortality was not correlated with
impaired viral clearance (panel E). Intravenous administration of clodronate does not deplete
phagocytic cells in peripheral lymph nodes and lungs and would not be expected to alter T
cell activation and clonal expansion in these locations. Consistent with these observations,
normal numbers of CD8+VSV-N T cells were detected in the CLN (panel F) and lungs (data
not shown). As expected, clodronate inhibited expansion of VSV-N T cells in the spleen
(data not shown).
Production of IFN–γ in the CNS is dependent on peripheral macrophages
To further examine the potential functional role of mΦ in the encephalitic brain, the primary
VSV-induced IFN-γ response was assessed in normal mice and mice rendered deficient of
mΦ by intravenous administration of liposome-encapsulated clodronate. Figure 5
demonstrates that only trace numbers of IFN-γsecreting cells were detected in the brain of
naïve MAFIA mice. However, this population expanded in the brains of VSV infected mice,
whereas clodronate treatment prior to virus infection markedly suppressed this response.
This was true when data was expressed either as the number of ELISPOTS/105 cells or total
number of ELISPOTS per brain (top and bottom panels, respectively). These data contrast
with prior studies where ablation of peripheral DCs in vivo failed to suppress this response
in the CNS (Ciavarra et al., 2006). The observation that the VSV-induced IFN-γ response is
normal in mice with a markedly reduced infiltrate following DC depletion suggests that a
resident cell type produces this cytokine. Why peripheral mΦ but not DCs are required for
this response remains to be clarified.
Perivascular and meningeal macrophages play an essential role in VSV encephalitis
Macrophages have documented APC activity in vivo (Pozzi et al., 2005) and within the
CNS, PVM are believed to be the foremost APC, a function ideally suited for their strategic
location at the BBB between the endothelial basement membrane and the glia limitans.
Clodronate-encapsulated liposomes are selectively engulfed by cerebral PVM/MM leading
to progressive intracellular accumulation of sodium clodronate that kills PVM by day 5 as a
result of adenosine triphosphate depletion (Russell and Rogers, 1999) and apoptosis (van
Rooijen et al., 1996). That PVM/MM can function as APCs is supported by the observation
that selective depletion of PVM and MM in vivo with clodronate mitigates clinical
symptoms associated with experimental allergic encephalomyelitis (EAE) and bacterial
meningitis (Polfliet et al., 2002; Polfliet et al., 2001b). To test whether VSV encephalitis is
dependent on these cells, we performed an ICV infusion of clodronate-encapsulated
liposomes following previously reported procedures. Mice were rested 3 days and then
infected with VSV via the intranasal route. VSV encephalitis was characterized 7 days post
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infection by flow cytometry (Figure 6A) and quantified based on calculated cell recoveries
(panels B, C). It is apparent from this study that ICV clodronate did not deplete resident
microglia (R2, panels a, b) or prevent VSV-induced expression of MHC class I antigens on
these cells indicating that microglial activation was not dependent on the presence of PVM/
MM (panels c, d). However, the inflammatory response was markedly impaired because the
accumulation of blood-derived leukocytes (CD45high) was suppressed by clodronate (R3,
panels a, b), a response that was primarily granulocytic (panels I, j). Accumulation of CD4+
and CD8+ T cell subsets as well as CD8+ VSV-specific T cells was similarly inhibited by
this treatment (panels e–h). Suppression of VSV encephalitis was also apparent when cell
recoveries were calculated (panel C). Seven days post-infection, the control mice given just
VSV were morbid, with one mouse exhibiting hind-limb paralysis. This mouse still had
some residual VSV in the brain although the remaining two moribund mice had undetectable
titers (panel D). This suggests that the observed morbidity may be related to the
inflammatory response and not to the cytopathic activity of the virus. Mice given ICV
clodronate were not moribund with no evidence of hind-limb paralysis and no detectable
VSV in their brains. Thus, ICV clodronate markedly suppressed VSV encephalitis and
reduced morbidity without altering viral clearance.
4. Discussion
In this report we have utilized two different approaches to assess whether monocytes and
tissue mΦ cells play an essential role in VSV encephalitis and viral clearance in the CNS. In
the MAFIA model peripheral depletion of mΦ was achieved after 5 daily injections of
dimerizer. Depletion was sustained in naïve (uninfected) mice because the peritoneum
remained devoid of EGFPhigh cells for at least two weeks. Although the c-fms gene is
expressed in mΦ and DCs (Rieser et al., 1998), the suicide gene is expressed an order of
magnitude lower in DCs than in mΦ (Burnett et al., 2004; Steel et al., 2008) and this may
explain the relative preservation of DCs following dimerizer treatment. Although a subset
(~30–40%) of microglia expressed EGFP, these cells remained intact during treatment with
dimerizer suggesting that AP20187 does not efficiently cross the BBB. Dimerizer treatment
also did not inhibit upregulation of microglial class II antigens and expansion of microglia
suggesting that microglia activation was independent of peripheral monocytes/macrophages.
Flow cytometric analysis of leukocytes isolated from VSV infected brains revealed a
prominent population of CD45highCD11b+ cells as well as a smaller infiltrate of CD11c+
DCs. At the time points investigated, we did not detect pDCs, B cells or NK cells in
encephalitic brains. Despite a relatively small infiltrate of CD45highCD11b-lymphoid cells,
CD8+ T cells were abundant suggesting activation-induced upregulation of CD11b, a view
confirmed by back-gating analysis (data not shown). A significant fraction of CD8+ T cells
bound tetramers demonstrating specificity for immunodominant nuclear protein epitope. The
specificity of the remaining activated T cells remains to be elucidated. Despite their dual
functionality as APCs and effector cells, mice rendered deficient of peripheral mΦ mounted
a normal inflammatory response in the CNS. Normal accumulation of CD8+VSV-N T cells
in the brain also implies preservation of peripheral DCs in dimerizer treated mice because
depletion of these cells markedly inhibits antiviral immunity and viral clearance (Steel et al.,
2009). MAFIA mice remained healthy during the course of this experiment suggesting
normal VSV clearance in the CNS in mice rendered deficient of peripheral mΦ.
The presence of a prominent infiltrate of CD45highCD11b+ cells raised the possibility that
some mΦ may have resisted depletion and/or the bone marrow rapidly replenished these
cells. To assess this possibility, lungs and spleens were also evaluated for the presence of
EGFP+ cells. As expected, AP20187 treatment markedly depleted EGFP+ cells in the lung
and to a lesser extent in the spleen (unpublished observation and (Steel et al., 2008). This
may reflect the ability of the spleen to function as a haematopoietic organ because treated
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mice developed splenomegaly and accumulated CD11b+Gr-1+ EGFPlow cells, a phenotype
typically expressed by immature monocytes/macrophages. Furthermore, flow cytometric
studies demonstrated that these cells were not mΦ but neutrophils based on histological
criteria and phenotype (CD45highCD11b+F4/80-Gr-1+). Gr-1+ cells represented infiltrating
neutrophils and not activated microglia because they had high expression of CD45 and were
F4/80−, whereas microglia were uniformly F4/80+ and remained Gr-1- during VSV
encephalitis (data not shown). These results are consistent with the work of Reiss and
colleagues who demonstrated an early VSV-induced infiltrate of neutrophils by
immunohistochemistry (Bi et al., 1995; Ireland and Reiss, 2006). In normal MAFIA bone
marrow essentially all CD45highCD11b+ cells expressed Gr-1 with approximately one-third
EGFPlow/int. VSV infection resulted in the selective disappearance of Gr-1+EGFPlow/int cells
from the bone marrow, whereas prior dimerizer treatment resulted in expansion of
Gr-1+EGFPlow/int cells. It seems likely that these cells emigrated from the bone marrow to
infiltrate the brain (and perhaps peritoneum) and contribute to the granulocytic response
seen in this organ. This view is consistent with the accumulation of
CD45highEGFPlow/intF4/80-Gr-1+ cells in the brains of mice depleted of mΦ. In contrast,
CD45highCD11b+ cells in the peritoneum were exclusively mΦ. Two mΦ populations based
on EGFP expression were present in the normal peritoneum. Macrophages with high EGFP
expression were dramatically reduced by VSV infection and this loss was exacerbated by
prior dimerizer treatment. Although the number of EGFPlow/int mΦ was also reduced by
virus infection, this population expanded in mice depleted of mΦ. Thus, peripheral depletion
of mΦ may have failed to suppress the inflammatory response in the brain because
neutrophils and not mΦ represented the predominant myeloid cell type in the encephalitic
brain. Mature neutrophils do not express the CSF-1 receptor (Hume et al., 2002) and would
be expected to be insensitive to AP20187 treatment. As noted previously, DCs have low
expression (tenfold lower relative to mΦ) of the transgene. This may have prevented
significant loss of these essential APCs resulting in normal clonal expansion of CD8+VSV-
N T cells in the CLN and subsequent CNS penetration. This speculation, however, will
require further investigation.
In striking contrast to this conditional ablation model, intravenous administration of
liposome-encapsulated clodronate into naïve MAFIA mice profoundly suppressed VSV
encephalitis. The impaired IFN-γ response may reflect the diminished numbers of T cells
that infiltrated the brains of mice depleted of mΦ if T cells represent the cellular source of
this cytokine. Clodronate treatment was associated with increased morbidity/mortality that
did not correlate with impaired viral clearance in the CNS. The different outcome achieved
with clodronate versus dimerizer may reflect the different populations targeted by these
treatments. In the MAFIA model, AP20187 dimerizer targets mΦ with high c-fms activity
and leaves relatively intact cells with low expression levels of the transgene such as DCs and
immature and mature granulocytes. Thus neutrophils are not depleted by dimerizer treatment
and are available to infiltrate the VSV infected brain. For the same reason, DCs presumably
in the draining cervical lymph nodes remain functional and capable of initiating and
sustaining a primary T cell-mediated immune response whose progeny accumulate in the
CNS. This is consistent with the observed normal clonal expansion of VSV-N T cells
detected in the CLN. With respect to clodronate, mΦ engulf liposomes and undergo
apoptosis. For reasons that are not clear, neutrophils are not eliminated by clodronate despite
their phagocytic activity (Qian et al., 1994) and are therefore available to infiltrate the VSV
infected brain. Their diminished numbers in the brain suggests that they may lack the ability
to penetrate the BBB. These different outcomes with clodronate versus AP20187 may reflect
the observation that clodronate also depletes marginal (CD8−) DCs in the spleen (Leenen et
al., 1998) and these cells may migrate to the brain where they play an essential role in the
disruption of the BBB. Most DCs in the encephalitic brain express a CD8− phenotype
(Figure 4, panels p–r). This view is consistent with the diminished infiltrate observed in
Steel et al. Page 8













brains of VSV infected transgenic mice depleted of peripheral DCs (Steel et al., 2009) and
the failure of Evans blue to penetrate the brain parenchyma of these animals (data not
shown). Similar observations have been reported in a murine influenza model where
prevention of DC migration from lymph nodes into the lung increased mortality, inhibited
viral clearance and pulmonary T cell responses (McGill et al., 2008). The importance of the
BBB in regulating encephalitis and viral clearance is highlighted in studies with lethal
silver-haired bat rabies virus. Virulent strains do not disrupt the BBB restricting leukocytes
influx into the brain parenchyma. Opening the BBB enhanced encephalitis, viral clearance
and survival (Roy and Hooper, 2007; Roy et al., 2007).
The brain contains two strategically located mΦ populations, PVM and MM, which
represent the major mΦ populations resident in the brain. Because of their strategic location
and the observation that CD8+ T cell infiltration is markedly enhanced by cognate antigen
recognition (Galea et al., 2007), they are ideally suited to function as APCs and to regulate
brain inflammation. Their function(s) in the CNS, however, remains poorly defined.
Recently, Polfliet and colleagues reported that ICV infusion of liposome-encapsulated
clodronate selectively depleted PVM/MM and left resident microglia intact (Polfliet et al.,
2001a). Depletion of PVM/MM by clodronate inhibited influx of leukocytes into the CNS
during pneumococcal meningitis despite elevated production of relevant chemokines and
adhesion molecules (Polfliet et al., 2001b). Clinical symptoms were exacerbated in treated
animals likely reflecting elevated production of inflammatory cytokines. Thus, in this
bacterial meningitis model PVM and MM play a protective role and suggest that these cells
facilitate leukocyte influx at the BBB. In contrast, PVM and MM have been implicated in
early disease progression during EAE (Polfliet et al., 2002). As demonstrated in this report,
delivery of clodronate directly into the brain profoundly suppressed leukocyte infiltration of
non-specific granulocytes and specific CD8+ VSV-N T cells. The latter observation was
unexpected because clodronate delivered into the brain does not deplete mΦ or DCs in the
draining CLN and therefore should not inhibit activation and clonal expansion of VSV-N T
cells. Thus, in the VSV model, depletion of CD8-marginal DCs or PVM/MM results in
similar consequences on VSV encephalitis, whereas this response remains intact in mice
depleted of peripheral mΦ (MAFIA model). How these different cell populations regulate
VSV encephalitis is currently unknown. Preliminary PCR array analyses suggest that
peripheral DCs are essential for a normal VSV-induced chemokine mRNA response in the
CNS (data not shown). Thus, loss of marginal DCs with clodronate may have contributed to
the impaired responses seen in these mice. The observation that depletion of PVMs appears
to impair VSV encephalitis in a similar manner suggests that these two populations regulate
VSV encephalitis in an apparent non-redundant fashion.
Studies with clodronate suggest that a robust leukocyte infiltrate is not essential for VSV
clearance and survival. This implies that efficient CNS viral clearance mechanisms exist
independent of infiltrating blood-derived leukocytes. This notion is supported by the
observation that astroyctes display the appropriate TLRs (TLR4/7) for VSV recognition and
triggering of these receptors leads to production of the antiviral protein IFNα (Carpentier et
al., 2005; McKimmie and Fazakerley, 2005). Microglia possess similar properties and
functions (Olson and Miller, 2004). Recent studies in mice with a cell type-specific IFN
receptor deletion in neuroectodermal cells of the CNS demonstrate the importance of local
production of type I IFN for VSV clearance and survival. Thus these mice die within 2–3
days post infection, whereas normal mice survive this dose of infection (Detje et al., 2009).
Interestingly, IFNα proteins levels in the brain of these mice were to low to detect by
ELISA, an observation that is consistent with prior reports that IFNα protein was detected in
the blood but not in the CNS during VSV encephalitis (Ciavarra et al., 2005; Trottier et al.,
2007). Resident astrocytes can also produce IFN-γ (Lau and Yu, 2001) which inhibits VSV
replication in the CNS (Kundig et al., 1993) likely by IFN-γ–dependent upregulation of type
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I NOS (Komatsu et al., 1996; Komatsu et al., 1999). Viral clearance and host recovery is
associated with NOS-1 expression in neurons and not other isoforms despite abundant and
early expression of inducible nitric oxide synthase (iNOS, NOS-2) in the OB (Komatsu et
al., 1999). In view of the exquisite sensitivity of VSV to the antiviral activity of types I/II
IFNs, it seems likely that this system contributes significantly to survival in the absence of a
significant infiltrate of leukocytes. In addition to the innate response, adaptive immunity
clearly contributes to VSV clearance and long-term survival. Thus, nude mice are healthy
initially following intranasal VSV infection because their innate defences are still intact, but
ultimately succumb between days 10–14 post infection to doses of VSV that are not lethal to
immunocompetent mice. CD4+ and CD8+ T cells infiltrate the brain around days 4–5
corresponding to the appearance of IFN-γ mRNA in the brain (Ireland and Reiss, 2006).
Mechanistically, VSV replication and viral protein synthesis in neurons are inhibited by
IFN-γ both in vitro and in vivo which correlates with upregulation of NOS-1 protein levels
and increased production of NO (Komatsu et al., 1996; Komatsu et al., 1999).
In summary, we have utilized two different approaches to deplete mΦ in vivo to access their
role in VSV encephalitis. When peripheral mΦ were depleted in a conditional ablation
transgenic model (MAFIA), VSV encephalitis was not impaired relative to control mice. In
striking contrast, treatment with clodronate-encapsulated liposomes, which also depletes
CD8− marginal DCs, inhibited VSV encephalitis. Similar results were observed when mice
were given clodronate via the ICV route where only PVM and MM were depleted. In all 3
experimental conditions, viral clearance remained relatively normal but not predictive of
morbidity/mortality. Thus, VSV encephalitis is regulated in an apparent non-redundant
fashion by two distinct phagocytic populations, CD8− DCs and PVMs, that reside in the
marginal sinus of the spleen and perivascular spaces in the brain, respectively. Gene
expression studies are currently underway to determine why peripheral DCs are essential for
an inflammatory response in the CNS. Quantitative PCR findings indicate that VSV
encephalitis is associated with a DC-dependent induction of chemokines and
proinflammatory cytokines (unpublished observation). Thus, DCs regulate leukocyte
infiltration because they are essential for chemokine production in the CNS, whereas PVMs
provide an unknown non-redundant function. Based on these and other studies, we propose a
model where resident glial cells produce chemokines but only after receiving a signal(s)
from infiltrating DCs, whereas PVMs are required for proinflammatory cytokine production
and disruption of the BBB facilitating leukocyte entry into the brain parenchyma. At the
dose used in this study, innate antiviral mechanisms are sufficient for viral clearance. We
further suggest that morbidity/mortality occurs despite viral clearance because brain PVMs
produce proinflammatory cytokines (TNFα, IL-1). Thus, clodronate given via the
intravenous route leaves brain PVMs intact resulting in morbidity, whereas ICV clodronate
eliminates these cells and mice remain healthy. Studies are currently underway to test the
validity of this model.
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Figure 1. Dimerizer treatment depletes EGFPhigh cells in MAFIA mice and induces a potent and
sustained accumulation of granulocytes in the peritoneal cavity
MAFIA mice were either untreated (mock) or depleted of mΦ by AP20187 treatment and
the following day peritoneal exudates cells (PECs) harvested for flow cytometric analysis.
(panel A) The top and bottom 3 panels represent PECs isolated from untreated and AP20187
treated mice, respectively. Panels a and d show the forward and side scatter plots with the
region indicating viable cells. Cells from the GFPhigh region in panels b and e (box and
circle, respectively) were sorted, subjected to cytospin centrifugation and stained with May-
Grunwald/Geimsa for microscopy (panels c and f). The GFPlow population in dimerizer
treated mice was also sorted and evaluated by microscopy (panel g). In panel B, viable
EGFPlow cells were gated and expression of F4/80 and Gr-1 evaluated by flow cytometry.
The decrease in F4/80 and increase in Gr-1 expression was statistically significant (T test,
α= 0.001). (panel C) Sustained accumulation of EGFPlow and Gr-1+ in the peritoneum of
MAFIA mice treated with AP20187. Day 1 values were not statistically significant for
EGFPlow and Gr-1+ cells (T test, α= 0.1). However, statistically significant differences
existed between the EGFPlow and Gr-1+ cells at 1 and 2 weeks in AP20187 versus mock
treated mice (α = 0.05)
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Figure 2. VSV encephalitis progresses normally following acute depletion of peripheral
macrophages
(panel A) MAFIA mice (5 mice/group) were treated for 5 days s with dimerizer and the
following day given a single intranasal application of VSV. Naïve B6 mice were used to
define EGFP-cells and to assess the number of leukocytes present in uninfected brains (first
column). MAFIA mice were given just AP20187 (2ndcolumn), VSV only (3rd column) or
AP20187 + VSV (4th column). Eight days post-infection, leukocytes were isolated from
brains, viable cells gated based on forward and side scatter characteristics and phenotyped
by multiparameter flow cytometry. Microglia were gated as CD45low/intCD11b+ (box,
panels a–d). The activation status of microglia was then accessed by MHC class II antigen
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expression (panels e–h). Conventional and pDCs were identified in a CD45highCD11b+ gate
using the indicated mAbs (panels i-l). VSV-N T cells were identified in gated CD8+ cells by
class I tetramer binding and co-expression of CD49d (panels m–p). (panel B) Data from this
and two additional experiments was pooled to calculate specific cell recoveries from the
brain (expressed as mean ±SEM) following the indicated treatments. No significant
differences in cell recoveries were detected between VSV infected mice that were either
untreated or treated with AP20187.
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Figure 3. Sustained depletion of EGFP+ macrophages in MAFIA mice during VSV encephalitis
MAFIA mice (4–6 mice/group) were treated with AP20187 intravenously for 5 consecutive
days and on the following day given an intranasal application of VSV (2×105 PFU). Six
days post infection, brain leukocytes were isolated along with bone marrow and peritoneal
exudates cells. Cells were incubated with the indicated mAbs and then phenotyped by flow
cytometry. (A) Cells were stained with mAbs to CD45 and CD11b to characterize the
inflammatory infiltrate in the brain (panels a–c) and to evaluate the consequences of
dimerizer treatment on leukocytes derived from the peritoneum (panels d–f) and bone
marrow (panels j–l). Co-expression of Gr-1 and EGFP on gated CD45highCD11b+ cells was
then evaluated on cells derived from the peritoneum (panels g–i) and bone marrow (m–o).
(B) The absolute number of cells of the indicated phenotype was calculated by multiplying
total leukocyte recoveries x percentage of cells with the selected phenotype. The experiment
was repeated a second time and yielded comparable results.
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Figure 4. Clodronate markedly suppresses viral encephalitis but not viral clearance in the CNS
Six MAFIA mice received a single injection (retro-orbital sinus) of liposome-encapsulated
clodronate and the following day inoculated with VSV (5×105 PFU) via the intranasal route.
Controls were either uninfected B6 (3 mice) or MAFIA mice given just VSV (4 mice).
Seven days post infection peripheral organs were pooled, homogenized and single cell
suspensions prepared from spleen and CLNs. Brain leukocytes were enriched on Percoll
gradients. Cells were stained with the indicated mAbs and analyzed by multi-parameter flow
cytometry. (panel A) Viable leukocytes were first defined based on forward and side scatter
characteristics (Region 1, R1) and within this gate microglia and the cellular infiltrate
defined as CD45low/int and CD45high cells, respectively (R2 and R3, panels a–c). The
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granulocyte composition of the brain was assessed broadly using the R1 gate (panels d–f)
and then specificity in the infiltrate (R3, panels g–l). Conventional, pDCs (panels m–o) and
CD11c+CD8+/− DCs (panels p–r) were also identified in the R1 gate. To identify VSV-N T
cells, tetramer binding and expression of the activation marker CD11a were determined on
gated CD8+ cells (panels s–u). (panels B, C). Cell recoveries from encephalitic brains of
untreated mice and mice treated with clodronate. Error bars represent SEM of a minimum of
3 experiments with 4–10 mice per group. Recoveries were calculated using either R3 (B) or
R1 gates (C). **p < 0.01 versus Cl2MBP + VSV, *p < 0.05 versus Cl2MBP + VSV
calculated by t test (GraphPad Prism 4). (panel D) Enhanced morbidity/mortality associated
with VSV encephalitis in mice treated with liposome-encapsulated clodronate. (panel E)
Depletion of peripheral mΦ did not inhibit viral clearance from the CNS. Comparable viral
titers were obtained when this experiment was repeated using 4–6 mice/group. (panel F)
Clonal expansion of VSV-N T cells in the draining CLN is not impaired in mice depleted of
peripheral mΦ (panel F). Tetramer+ (Tet+) cells were identified in gated CD8+ cells.
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Figure 5. Ablation of peripheral macrophages suppresses the VSV-induced interferon gamma
response in the CNS
MAFIA mice (3–6 per group) were either untreated or given intravenous clodronate. The
following day mice were infected with VSV via the intranasal route and brain leukocytes
isolated seven days post infection. An IFN-γ ELISPOT assay was then performed as
previously described using six replicates per input cell number (Ciavarra et al., 2006). Cells
were not re-stimulated with VSV in vitro to more accurately estimate the number of
cytokine-producing cells in vivo. Data are expressed as either the number of cytokine-
producing cells/105 cells (upper panel) or total number of cytokine-producing cells per brain
(bottom panel).
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Figure 6. Impaired antiviral immune responses in the CNS of mice rendered deficient of
perivascular macrophages
MAFIA mice were depleted of perivascular mΦ by surgical administration of 8μL
clodronate-liposomes into the left lateral ventricle of the brain (ICV injection). Mice were
allowed to recover from surgery for 3 days and then given an intranasal application of VSV.
Seven days post-infection, mice were euthanized to harvest brain tissue for plaque assay or
flow cytometry. (panel A) Multicolour flow cytometry was performed on brains leukocytes
derived from VSV infected mice that were either untreated (VSV, panels a, c, e, g, i) or
given a prior ICV injection of clodronate (Cl2MBP + VSV, panels b, d, f, h, j). Microglia
were gated as CD45int/low ((R2, panels a, b) and co-expression of CD11c and MHC class I
determined (panels c, d). T cells specific for VSV were defined as tetramer+CD49d+ cells
located in gated CD8+ cells (panels e, f). Infiltrating CD4+ cells with unknown specificity
were also detected in brains of infected mice (panels g, h). (panel B) Cell recoveries of
microglia expressing the indicated phenotype. Error bars represent SEM of experiments with
4–6 mice per group. (panel C) Calculated cell recoveries of the indicated leukocyte
populations. **p < 0.01 versus Cl2MBP + VSV, *p < 0.05 versus Cl2MBP + VSV
calculated by t test (GraphPad Prism 4). (panel D) VSV titers in the brains of untreated
(VSV) or clordronate treated mice (Cl2MBP+VSV). Similar viral titers were obtained when
this experiment was repeated using 4–6 mice/group.
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